Cargando…
Efficacy and safety of generic escitalopram versus Lexapro in the treatment of major depression: a multicenter double-blinded randomized controlled trial
BACKGROUND: Depression is an increasingly important public health problem in China, but only a small minority of patients with this condition receive treatment. One of the reasons for low treatment rates is the relatively high cost of imported antidepressant medications. AIM: Compare the efficacy an...
Autores principales: | Yu, Yimin, Li, Huafang, Wang, Biao, Li, Keqing, Xu, Xiufeng, Shi, Jianguo, Gao, Chengge, Tan, Qingrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of the Shanghai Archives of Psychiatry
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054541/ https://www.ncbi.nlm.nih.gov/pubmed/24991142 http://dx.doi.org/10.3969/j.issn.1002-0829.2013.02.007 |
Ejemplares similares
-
Treatment of major depressive disorders with generic
duloxetine and paroxetine: a multi-centered, double-blind,
double-dummy, randomized controlled clinical trial
por: WANG, Zhiyang, et al.
Publicado: (2015) -
Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
por: Jeong, Jong-Hyun, et al.
Publicado: (2015) -
PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
por: Jeong, Jong-Hyun, et al.
Publicado: (2016) -
Efficacy of escitalopram monotherapy in the treatment of major depressive disorder: A pooled analysis of 4 Chinese clinical trials
por: Li, Guanjun, et al.
Publicado: (2017) -
An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus
Escitalopram in Major Depression
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2022)